Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03869684
What this trial is testing

Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Senju Pharmaceutical Co., Ltd. 13
Early research (Phase 1)UnknownNCT05005884
What this trial is testing

Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 80
Not applicableUnknownNCT01676506
What this trial is testing

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Russian Academy of Medical Sciences 300
Post-approval studies (Phase 4)Study completedNCT02060604
What this trial is testing

Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Università degli Studi di Brescia 60
Not applicableLooking for participantsNCT07515521
What this trial is testing

Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD

Who this might be right for
Age - Related Macular Degeneration (AMD)
Maximilian Pfau 150
Not applicableEnded earlyNCT00993330
What this trial is testing

Macular Pigment Optical Density in Healthy Subjects

Who this might be right for
Age Related Macular Degeneration
Medical University of Vienna 96
Testing effectiveness (Phase 2)Study completedNCT05456828
What this trial is testing

ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Visara, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT02713204
What this trial is testing

Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 365
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Post-approval studies (Phase 4)Study completedNCT03022292
What this trial is testing

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Who this might be right for
Wet Macular Degeneration
University of California, Los Angeles 26
Early research (Phase 1)Active Not RecruitingNCT06198413
What this trial is testing

LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Innostellar Biotherapeutics Co.,Ltd 12
Very early researchUnknownNCT02868424
What this trial is testing

Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation

Who this might be right for
Age Related Macular DegenerationMacular DegenerationAMD
The First Affiliated Hospital with Nanjing Medical University 6
Testing effectiveness (Phase 2)Study completedNCT00138632
What this trial is testing

Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis 50
Testing effectiveness (Phase 2)WithdrawnNCT02895815
What this trial is testing

Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)

Who this might be right for
Visual AcuityGeographic AtrophyMacular Degeneration
Janssen Pharmaceutical K.K.
Not applicableStudy completedNCT00494325
What this trial is testing

The Role of Macular Pigment in Patients With Age-related Macular Degeneration

Who this might be right for
Age Related Maculopathy
Insel Gruppe AG, University Hospital Bern 480
Not applicableEnded earlyNCT00001310
What this trial is testing

Tissue Studies of Human Eye Diseases

Who this might be right for
Retinal DiseaseCorneal DiseaseDiabetic Retinopathy+2 more
National Eye Institute (NEI) 3,833
Not applicableLooking for participantsNCT06899360
What this trial is testing

Evaluation of Clinical Progression, Prognostic Factors, and Quality of Life in Patients with Age-related Macular Degeneration.

Who this might be right for
Age-Related Macular Degeneration
University of Udine 200
Not applicableStudy completedNCT02126423
What this trial is testing

Resistance to Antibiotics in Patients Receiving Eye Injections

Who this might be right for
Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Retinopathy
Prism Vision Group 40
Not applicableLooking for participantsNCT07555574
What this trial is testing

Defining Retinal Structures Using Hyperspectral Retinal Imaging

Who this might be right for
Age-Related Macular DegenerationDiabetic RetinopathyGlaucoma+2 more
Center for Eye Research Australia 1,000
Post-approval studies (Phase 4)Study completedNCT02130024
What this trial is testing

A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 281
Next Page